Lipids Market Intelligence

Industry Outlook & Drivers

Global Market Outlook on Lipids

Global lipids market was valued to be at USD 6.5 billion and is poised to grow at a CAGR of 9.4 percent from 2017 to 2022 to reach $11.2 billion by 2022.

• Growth is attributed to meet requirements of ageing populations and infants
• Prevalence of chronic diseases and changing food habits contribute to the intake of supplements and energy providing food
• Increasing industrialization, and growing health consciousness and awareness about the health benefits of lipids

Market Overview – Supply Demand

As pharma companies are focusing on improving the bioavailability of drugs, more lipid based carrier molecules are expected to hit the market thereby increasing the demand

Supply

• Supply market is medium with few lipid based formulations manufactured from plant and vegetable oils
• Currently there are 4-5 major CMOs in the market and they may not be able to support the growing demand, once all drugs lined up for regulatory approval get market authorisation
• With opportunities lining up for the manufacture of lipid products, major players are believed to expand their existing capacities

Demand

• Demand for nutritional lipids is driven by the nutraceutical and food industry because of ageing population and high intake of supplements
• On considering pharmaceutical industry, demand will be boosted by more drugs entering the market, there will be increased reliance on CMOs for their manufacturing expertise and experience
• But due to the consolidated supply market, supply is shortened compared to demand

Market Trends

Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery, clinical medicine and research, as well as in other varied sciences

• Ascendia Pharmaceuticals has  developed new approaches using Lipid based nanotechnology to dissolve and stabilize poor water soluble molecules
• Gattefossé USA a leading manufacturer of lipid excipients  develops new formulations for oral and topical drug delivery to improve bioavailability
• Merck Starts Distribution of Avanti Polar Lipids for research and pharmaceutical product development in Korea
• Millipore Sigma Signs Distribution Agreement with Avanti® Polar Lipids